LINC00888 competes with the gene transferrin receptor (TFRC) for the chance of interacting with miR-378 g and leads to the upregulation of TFRC, thereby accelerating laryngeal cancer cell growth and mobility [40]. This evidence concerns the gene TFRC and laryngeal carcinoma.